HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

A

Agilent Technologies, Inc. (NYSE)

Healthcare — Diagnostics & Research

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Buy 1.6 / 5 18 analysts
$130.69
$-2.70 (-2.02%)
Target: $160.33 (22.7%)
Sign in to add A to a watchlist or set price alerts.

Price History

Fundamentals

Market Cap$37.86B
P/E Ratio (TTM)26.92
Forward P/E20.27
EPS (TTM)$4.98
Dividend Yield0.77%
Profit Margin19.55%
Revenue Growth-
ROE-
Debt/Equity-
Recommendation Buy 1.6
Analyst Target$160.33
Analysts18
Indexes NYSE

Technical Indicators

RSI (14)55.5
Beta1.26
SMA 20-
SMA 40-
52-Week High-
52-Week Low-
50-Day Avg-
200-Day Avg-
Avg Volume$2.30M
Volume$2.17M

Performance Analysis

BULLISH

A shows predominantly bullish signals based on its fundamentals and technicals.

+ RSI at 55.5 shows positive momentum.
+ Wall Street consensus is "Buy" from 18 analysts.
+ Average analyst target of $160.33 implies 22.7% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 01, 2026 15:01 UTC

Back to Screener Export Report